It copies both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which help control blood sugar and reduce appetite
A clinical consultation and eligibility screening are required prior to dispensing
Most people may get mild side effects like feeling sick, but this can get better as the body gets used to it
TDM received speaking fees within the last 3 years from Novo Nordisk, Eli Lilly, AstraZeneca, Merck, Berlin Chemie AG, and Mercodia
doi: 10.1038/nm.2002 154 DornelesGPda SilvaIBoeiraMCValentiniDFonsecaSGDal LagoPet al
Global Zepbound Market Size and Forecast 2026 to 2033 The global Zepbound market is estimated to be valued at USD 10.37 Bn in 2026 and is expected to reach USD 31.68 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 17.3% from 2026 to 2033